Prestigious award recognizes promising postgraduate researchers in molecular biology
Chalfont St Giles, UK -- June 15, 2011 - The deadline to enter the 2011 GE and Science Prize for Young Life Scientists is 1st August 2011. Established in 1995, the prize recognizes outstanding young scientists from around the world who have completed their PhDs in the area of molecular biology* during 2010.
Research examines lessons learnt from leading low carbon economies in carbon productivity and policy efficiency
Sydney, 26th May 2011 - A report by Vivid Economics and Norton Rose, commissioned by GE (NYSE:GE), today revealed that it is possible for economies to reduce carbon emissions while maintaining economic growth and prosperity; and that Australia is lagging behind its trading partners in achieving this.
GE Healthcare showcases Molecular Imaging advances at Society of Nuclear Medicine designed to reduce cost, increase access and improve quality
San Antonio, Texas -- June 3, 2011--- Investing and innovating in ways that break through cost, quality and access barriers to health for individuals and entire health systems, GE Healthcare is highlighting an advanced portfolio of molecular imaging technologies at the 58th annual meeting of the Society of Nuclear Medicine (SNM), June 4-8, in San Antonio.
Sydney, Australia: GE Capital Australia and New Zealand has today signed an agreement to sell approximately $5 billion dollars in mortgages to Pepper Homeloans, in a sale that marks the final phase of its withdrawal from its home lending business in Australia and New Zealand.
"This transaction aligns with GE Capital's strategy to become Australia and New Zealand's leading specialist financial services provider," said Skander Malcolm, President and CEO, GE Capital Australia & New Zealand.
Auckland: GE Capital's New Zealand Equipment Finance business has acquired over NZ$100 million of commercial loan assets from Face Finance Limited, a subsidiary of South Canterbury Finance.
The deal consolidates GE Capital's position as a specialist financial service provider and complements its equipment finance offering in the New Zealand market.
PARIS -- MAY 18, 2011 -- In line with its healthymagination strategy, GE Healthcare introduced today the Innova* 2100-IQ (Optima* Edition), a cost effective, dedicated interventional cardiology (IC) system designed to meet the growing need for basic IC procedures. Based on the company's reliable, high-performance Innova platform, this new configuration offers excellent image quality and dose efficiency at a lower price point and total cost of ownership.
